Germline variants associated with breast cancer in Khakass women of North Asia

Mol Biol Rep. 2023 Mar;50(3):2335-2341. doi: 10.1007/s11033-022-08215-1. Epub 2022 Dec 28.

Abstract

Introduction: Variants in the BRCA1/2 genes are responsible for familial breast cancer. Numerous studies showed a different spectrum of BRCA variants among breast cancer patients of different Ethnicity origin. In the available literature, no previous research has focused on breast cancer-associated variants among the Khakass people (the indigenous people of the Russian Federation).

Methods: Twenty-six Khakass breast cancer patients were enrolled in the study. Genomic DNA was isolated from blood samples and used to prepare libraries using a Hereditary Cancer Solution kit. Next-generation sequencing (NGS) was performed using the MiSeq System (Illumina, USA).

Results: In our study, 12% of patients (3/26) carried a single pathogenic variant; 54% of patients (14/26) carried variants of uncertain significance (VUS) or conflicting variants; and 35% of patients (9/26) did not carry any clinically significant variants. Germline pathogenic variant in the ATM gene (rs780619951, NC_000011.10:g.108259022C > T) was identified in two unrelated patients with a family history of cancer (7.6%, 2/26). The pathogenic truncating variant in the ATM gene (p. R805* or c.2413C > T) leads to the nonfunctional version of the protein. This variant has been earlier reported in individuals with a family history of breast cancer.

Conclusions: Our pilot study describes the germline variant in the ATM gene associated with breast cancer in Khakass women of North Asia.

Keywords: BRCA; Breast cancer; Germline variant; Indigenous peoples; Khakass; Peoples under threat.

MeSH terms

  • Breast Neoplasms* / epidemiology
  • Breast Neoplasms* / genetics
  • Breast Neoplasms* / pathology
  • Female
  • Genetic Predisposition to Disease
  • Germ Cells
  • Germ-Line Mutation / genetics
  • Humans
  • Pilot Projects
  • Russia

Substances

  • ATM protein, human